Dr. Nisreen J. Ezzi, M.D
Family Medicine (Family Medicine Physician)
- Medicare participating
At a glance
- Years since graduation
- 26
- In the NPI registry since
- 2009
- Medicare patients seen, 2024
- 82
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2009Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
NY license 252519
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 82
- Services billed
- 556
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 218 | 78 |
| Established patient office or other outpatient visit, 20-29 minutes | 208 | 69 |
| Insertion of needle into vein for collection of blood sample | 84 | 53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | 21 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | 23 |
| Test to measure expiratory airflow and volume | 13 | 13 |
| Placement of ear probe for computerized measurement of sound with interpretation and report | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 80 payments worth $1,515 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $262 |
|---|---|
| GlaxoSmithKline, LLC. | $219 |
| AbbVie Inc. | $161 |
| Novo Nordisk Inc | $124 |
| Scilex Pharmaceuticals Inc. | $104 |
| Pfizer Inc. | $67.45 |
| Amgen Inc. | $55.13 |
| Lilly USA, LLC | $54.44 |
| Food and Beverage | $1,515 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.